Cytokine control of memory T-cell development and survival, Nat. Rev. Immunol, vol.3, pp.269-279, 2003. ,
Memory T cells need CD28 costimulation to remember, Semin. Immunol, vol.21, pp.69-77, 2009. ,
Duration of TCR stimulation determines costimulatory requirement of T cells, Immunity, vol.5, pp.41-52, 1996. ,
T cell activation determined by T cell receptor number and tunable thresholds, Science, vol.273, pp.104-106, 1996. ,
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory, J. Immunol, vol.167, pp.5565-5573, 2001. ,
Induction and visualization of mucosal memory CD8 T cells following systemic virus infection, J. Immunol, vol.163, pp.4125-4132, 1999. ,
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates, Nat. Med, vol.15, pp.746-749, 2009. ,
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates, Sci. Transl. Med, vol.3, pp.86-51, 2011. ,
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T-cells, Br. J. Pharmacol, vol.161, pp.512-526, 2010. ,
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28, MAbs, vol.6, pp.697-707, 2014. ,
A more selective costimulatory blockade of the CD28-B7 pathway, Transpl. Int, vol.24, pp.2-11, 2011. ,
Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker, Immunotherapy, vol.2, pp.625-636, 2010. ,
High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept, Am. J. Transplant, vol.14, pp.607-614, 2014. ,
CD28-specific immunomodulating antibodies: what can be learned from experimental models?, Am. J. Transplant, vol.12, pp.1682-1690, 2012. ,
Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation, Sci. Transl. Med, vol.2, pp.17-27, 2010. ,
Myeloidderived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion, J. Immunol, vol.180, pp.7898-7906, 2008. ,
Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5, J. Immunol, vol.188, pp.4209-4216, 2012. ,
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner, Am. J. Transplant, vol.11, pp.1599-1609, 2011. ,
Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells, PLoS One, vol.8, p.83139, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02165637
Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab9 antibody, Am. J. Transplant, vol.12, pp.2630-2640, 2012. ,
Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain, MAbs, vol.5, pp.47-55, 2013. ,
Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3 + )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates, Clin. Exp. Immunol, vol.164, pp.265-274, 2011. ,
FR104, an antagonist anti-CD28 monovalent Fab9 antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft, Am. J. Transplant, vol.15, pp.88-100, 2015. ,
Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis, J. Immunol, vol.194, pp.1454-1466, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148517
Neuropathogenesis of herpesvirus papio 2 in mice parallels infection with Cercopithecine herpesvirus 1 (B virus) in humans, J. Gen. Virol, vol.87, pp.267-276, 2006. ,
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates, Proc. Natl. Acad. Sci. USA, vol.84, pp.1369-1373, 1987. ,
Homeostatic proliferation is a barrier to transplantation tolerance, Nat. Med, vol.10, pp.87-92, 2004. ,
Heterologous immunity: an overlooked barrier to tolerance, Immunol. Rev, vol.196, pp.147-160, 2003. ,
LFA-1-specific therapy prolongs allograft survival in rhesus macaques, J. Clin. Invest, vol.120, pp.4520-4531, 2010. ,
The alloand viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation, Am. J. Transplant, vol.14, pp.319-332, 2014. ,
Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade, J. Immunol, vol.192, pp.2495-2504, 2014. ,
Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge, Immunology, vol.128, issue.1, pp.471-478, 2009. ,
Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28, Blood, vol.109, pp.2968-2977, 2007. ,
FR255734, a humanized, Fc-silent, anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model, J. Invest. Dermatol, vol.128, pp.1969-1976, 2008. ,
Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities, Transplantation, vol.83, pp.304-313, 2007. ,
Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4, Immunity, vol.41, pp.1013-1025, 2014. ,
The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells, Immunity, vol.41, pp.1026-1039, 2014. ,
CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement, Proc. Natl. Acad. Sci. USA, vol.112, pp.524-529, 2015. ,
Circulating T follicular regulatory and helper cells have memory-like properties, J. Clin. Invest, vol.124, pp.5191-5204, 2014. ,
Follicular helper T-cell memory: establishing new frontiers during antibody response, Immunol. Cell Biol, vol.92, pp.57-63, 2014. ,
T-follicular helper cells survive as long-term memory cells, Eur. J. Immunol, vol.42, pp.1981-1988, 2012. ,
Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons, Am. J. Transplant, vol.15, pp.358-370, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02148475
Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons, Transplant. Proc, vol.43, pp.3426-3430, 2011. ,
Recombinant human C1-inhibitor inhibits cytotoxicity induced by allo-and xenoantibodies, Transplant. Proc, vol.40, pp.581-583, 2008. ,
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties, Am. J. Transplant, vol.5, pp.443-453, 2005. ,
Immune competence after alemtuzumab treatment of multiple sclerosis, Neurology, vol.81, pp.872-876, 2013. ,
Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children, J. Immunotoxicol, vol.10, pp.387-392, 2013. ,
Differential T cell costimulatory requirements in CD28-deficient mice, Science, vol.261, pp.609-612, 1993. ,
Risk of posttransplant lymphoproliferative disorder associated with use of belatacept, Am. J. Health Syst. Pharm, vol.70, pp.1977-1983, 2013. ,